Clinical Trial Update: Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir [Phase 4]

View source ↗

Summary

Phase 4 trial update for combining Fuzheng Huayu with entecavir in liver cirrhosis due to hepatitis B virus; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis Due to Hepatitis Virus

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Fuzheng Huayu

Snippet

Sponsor: ShuGuang Hospital | Conditions: Liver Cirrhosis Due to Hepatitis B Virus | Phase 4 | Status: UNKNOWN